Child Behavior Disorders |
Bullying |
Clinical Trial: HIV Counseling Intervention for Methadone-Maintained Patients - 2
This study has been completed.
Purpose
The purpose of this study is to evaluate HIV counseling intervention for Methadone-Maintained Patients.
| Condition | Treatment or Intervention | Phase |
|---|---|---|
| Opioid-Related Disorders | Behavior: Behavior Therapy | Phase I |
MedlinePlus related topics: Drug Abuse
Study Type: Interventional
Study Design: Prevention, Randomized, Uncontrolled
Official Title: HIV Counseling Intervention for Methadone-Maintained Patients
Expected Total Enrollment: 104
Study start: October 1999
The purpose of this proposal is to evaluate, in methadone-maintained patients the association between an ADHD diagnosis and high-risk HIV/Hepatitis behavior. In addition, we would like to determine whether a new manually-guided HIV intervention; RISE: Reduce high risk Intravenous drug use and unsafe Sexual Encounters is superior to standard HIV/Hepatitis psycho-education.
Eligibility
Ages Eligible for Study: 18 Years - 60 Years, Genders Eligible for Study: Both
Criteria
Inclusion Criteria:
- Must meet DSM-IV criteria for opiate dependence and currently in methadone maintenance treatment
- Able to give informed consent and capable of complying with study procedures
- Women who are of childbearing age and/or pregnant may be included
- Individuals who are HIV-positive or have Acquired Immunodeficiency Syndrome may be included
- Patients who demonstrate moderate to high HIV risk behaviors will be included
- Patients with low to no HIV risk behaviors will be excluded
- Patients receiving a stable dose of methadone for three weeks will be included
Exclusion Criteria:
- Currently meets DSM-IV criteria for current Axis I psychiatric disorders (other than ADHD or substance abuse) which requires medical intervention, i.e., active suicide ideation, active psychosis, anxiety disorders, depression requiring hospitalization
- Patients who have exhibited suicidal or homicidal behavior within the past two years
- HIV positive patients must have knowledge of their status for a minimum of three weeks
Location Information
New York
Research Foundation for Mental Hygiene, Inc., New York, New York, 10032, United States
Frances R Levin, M.D., Principal Investigator, Research Foundation for Mental Hygiene, Inc.
More Information
Record last reviewed: July 2003
Last Updated: February 16, 2005
Record first received: May 21, 2003
ClinicalTrials.gov Identifier: NCT00061100
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 9, 2005

Not Signed In -


